Phibro Animal Health (PAHC) to Release Earnings on Monday

Phibro Animal Health (NASDAQ:PAHC) is scheduled to release its earnings data after the market closes on Monday, February 5th. Analysts expect Phibro Animal Health to post earnings of $0.39 per share for the quarter. Phibro Animal Health has set its FY18 guidance at $1.55-1.61 EPS.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The business had revenue of $193.40 million for the quarter, compared to analysts’ expectations of $189.89 million. During the same quarter in the prior year, the business earned $0.36 EPS. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Shares of Phibro Animal Health (PAHC) opened at $35.85 on Monday. Phibro Animal Health has a 12 month low of $26.10 and a 12 month high of $40.25. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91. The firm has a market capitalization of $1,450.61, a price-to-earnings ratio of 21.09, a P/E/G ratio of 4.23 and a beta of 1.27.

A number of research firms recently weighed in on PAHC. BidaskClub cut Phibro Animal Health from a “sell” rating to a “strong sell” rating in a research note on Tuesday, December 12th. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Monday, January 8th. Piper Jaffray Companies restated a “buy” rating and issued a $42.00 price target on shares of Phibro Animal Health in a research note on Friday, November 10th. Finally, ValuEngine cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $38.25.

COPYRIGHT VIOLATION NOTICE: This story was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Earnings History for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with's FREE daily email newsletter.

Leave a Reply